CCL2 and nasopharyngeal carcinoma: The expression level of MPC-1 is significantly associated with clinical stage, there is significant difference between four clinical stages (P = 0.034, one-way ANOVA, Fig 2), suggesting that MCP-1 might be a biomarker in the genesis and development process of NPC.